These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32343311)

  • 21. Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival.
    Fei DL; Motowski H; Chatrikhi R; Prasad S; Yu J; Gao S; Kielkopf CL; Bradley RK; Varmus H
    PLoS Genet; 2016 Oct; 12(10):e1006384. PubMed ID: 27776121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas.
    Esfahani MS; Lee LJ; Jeon YJ; Flynn RA; Stehr H; Hui AB; Ishisoko N; Kildebeck E; Newman AM; Bratman SV; Porteus MH; Chang HY; Alizadeh AA; Diehn M
    Nat Commun; 2019 Dec; 10(1):5712. PubMed ID: 31836708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.
    Wang H; Guo Y; Dong Z; Li T; Xie X; Wan D; Jiang Z; Yu J; Guo R
    Sci Rep; 2020 Oct; 10(1):18622. PubMed ID: 33122737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative Profiling of Alternative Splicing Induced by
    Kim S; Park C; Jun Y; Lee S; Jung Y; Kim J
    Mol Cells; 2018 Aug; 41(8):733-741. PubMed ID: 29991672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas.
    Chen C; Zhou P; Zhang Z; Liu Y
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):740-747. PubMed ID: 35434831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
    Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR
    Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-Atom Simulations Elucidate the Impact of U2AF2 Cancer-Associated Mutations on Pre-mRNA Recognition.
    Rozza R; Saltalamacchia A; Orrico C; Janoš P; Magistrato A
    J Chem Inf Model; 2022 Dec; 62(24):6691-6703. PubMed ID: 36040856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
    Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
    Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians.
    Kim SY; Kim K; Hwang B; Im K; Park SN; Kim JA; Hwang SM; Bang D; Lee DS
    Leuk Res; 2017 Oct; 61():96-103. PubMed ID: 28938223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
    Martínez-Valiente C; Garcia-Ruiz C; Rosón B; Liquori A; González-Romero E; Fernández-González R; Gómez-Redondo I; Cervera J; Gutiérrez-Adán A; Sanjuan-Pla A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
    Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
    PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Full-length transcript alterations in human bronchial epithelial cells with
    Soulette CM; Hrabeta-Robinson E; Arevalo C; Felton C; Tang AD; Marin MG; Brooks AN
    Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37487637
    [No Abstract]   [Full Text] [Related]  

  • 33. An autoinhibitory intramolecular interaction proof-reads RNA recognition by the essential splicing factor U2AF2.
    Kang HS; Sánchez-Rico C; Ebersberger S; Sutandy FXR; Busch A; Welte T; Stehle R; Hipp C; Schulz L; Buchbender A; Zarnack K; König J; Sattler M
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7140-7149. PubMed ID: 32188783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An extended U2AF(65)-RNA-binding domain recognizes the 3' splice site signal.
    Agrawal AA; Salsi E; Chatrikhi R; Henderson S; Jenkins JL; Green MR; Ermolenko DN; Kielkopf CL
    Nat Commun; 2016 Mar; 7():10950. PubMed ID: 26952537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
    Nagehan P; Sabbir M; Song J; Mohammad H
    J Clin Exp Hematop; 2023; 63(3):173-176. PubMed ID: 37766563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.
    Pellagatti A; Armstrong RN; Steeples V; Sharma E; Repapi E; Singh S; Sanchi A; Radujkovic A; Horn P; Dolatshad H; Roy S; Broxholme J; Lockstone H; Taylor S; Giagounidis A; Vyas P; Schuh A; Hamblin A; Papaemmanuil E; Killick S; Malcovati L; Hennrich ML; Gavin AC; Ho AD; Luft T; Hellström-Lindberg E; Cazzola M; Smith CWJ; Smith S; Boultwood J
    Blood; 2018 Sep; 132(12):1225-1240. PubMed ID: 29930011
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
    Graubert TA; Shen D; Ding L; Okeyo-Owuor T; Lunn CL; Shao J; Krysiak K; Harris CC; Koboldt DC; Larson DE; McLellan MD; Dooling DJ; Abbott RM; Fulton RS; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Grillot M; Baty J; Heath S; Frater JL; Nasim T; Link DC; Tomasson MH; Westervelt P; DiPersio JF; Mardis ER; Ley TJ; Wilson RK; Walter MJ
    Nat Genet; 2011 Dec; 44(1):53-7. PubMed ID: 22158538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
    Qiu J; Zhou B; Thol F; Zhou Y; Chen L; Shao C; DeBoever C; Hou J; Li H; Chaturvedi A; Ganser A; Bejar R; Zhang DE; Fu XD; Heuser M
    RNA; 2016 Oct; 22(10):1535-49. PubMed ID: 27492256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes.
    Nguyen HD; Leong WY; Li W; Reddy PNG; Sullivan JD; Walter MJ; Zou L; Graubert TA
    Cancer Res; 2018 Sep; 78(18):5363-5374. PubMed ID: 30054334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.
    Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M
    Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.